BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 De Hert M, Mazereel V, Stroobants M, De Picker L, Van Assche K, Detraux J. COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review. Front Psychiatry 2021;12:798554. [PMID: 35095612 DOI: 10.3389/fpsyt.2021.798554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Farmani AR, Mahdavinezhad F, Scagnolari C, Kouhestani M, Mohammadi S, Ai J, Shoormeij MH, Rezaei N. An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19. Drug Deliv Transl Res 2021. [PMID: 34542840 DOI: 10.1007/s13346-021-01067-5] [Reference Citation Analysis]
3 Clough E, Chean KT, Inigo J, Tubbesing KE, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, Schwartz SA, Khmaladze A, Mahajan SD. Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. J Neuroimmune Pharmacol 2021. [PMID: 34599743 DOI: 10.1007/s11481-021-10015-6] [Reference Citation Analysis]
4 Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, Oli AN, Dhingra S, Tor MA, Etando A, Kumar S, Irfan M, Gowere M, Chowdhury K, Akter F, Jahan D, Schellack N, Haque M. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life 2022;12:478. [DOI: 10.3390/life12040478] [Reference Citation Analysis]
5 Zhang C, Wang X, Wang C, He C, Ma Q, Li J, Wang W, Xu YT, Wang T. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation. Front Pharmacol 2021;12:790072. [PMID: 35002723 DOI: 10.3389/fphar.2021.790072] [Reference Citation Analysis]
6 Hasan MJ, Rabbani R, Anam AM, Huq SMR. Therapeutic safety and efficacy of triple-immunosuppressants versus dual-immunosuppressants in severe-to-critical COVID-19: a prospective cohort study in Bangladesh. Ann Med 2022;54:723-32. [PMID: 35238257 DOI: 10.1080/07853890.2022.2039958] [Reference Citation Analysis]
7 Dimai S, Semmler L, Prabhu A, Stachelscheid H, Huettemeister J, Klaucke SC, Lacour P, Blaschke F, Kruse J, Parwani A, Boldt LH, Bullinger L, Pieske BM, Heinzel FR, Hohendanner F. COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab. PLoS One 2021;16:e0255976. [PMID: 34411149 DOI: 10.1371/journal.pone.0255976] [Reference Citation Analysis]
8 López-Cortés A, Guerrero S, Ortiz-Prado E, Yumiceba V, Vera-Guapi A, León Cáceres Á, Simbaña-Rivera K, Gómez-Jaramillo AM, Echeverría-Garcés G, García-Cárdenas JM, Guevara-Ramírez P, Cabrera-Andrade A, Puig San Andrés L, Cevallos-Robalino D, Bautista J, Armendáriz-Castillo I, Pérez-Villa A, Abad-Sojos A, Ramos-Medina MJ, León-Sosa A, Abarca E, Pérez-Meza ÁA, Nieto-Jaramillo K, Jácome AV, Morillo A, Arias-Erazo F, Fuenmayor-González L, Quiñones LA, Kyriakidis NC. Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials. Front Pharmacol 2022;13:833174. [PMID: 35422702 DOI: 10.3389/fphar.2022.833174] [Reference Citation Analysis]
9 Narożna M, Rubiś B. Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. Int J Mol Sci 2021;22:8663. [PMID: 34445368 DOI: 10.3390/ijms22168663] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cui Y, Sun Y, Sun J, Liang H, Ding X, Sun X, Wang D, Sun T. Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. Infect Dis Ther 2021. [PMID: 34389970 DOI: 10.1007/s40121-021-00518-3] [Reference Citation Analysis]
11 Heydarian M, Mohammadtaghizadeh M, Shojaei M, Babazadeh M, Abbasian S, Amrovani M. The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword. Mol Biol Rep 2021. [PMID: 34657251 DOI: 10.1007/s11033-021-06800-4] [Reference Citation Analysis]
12 Ghazanfari D, Courreges MC, Belinski L, Bergmeier SC, McCall KD, Goetz DJ. Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19. Biochem Biophys Res Commun 2022;605:171-6. [PMID: 35367865 DOI: 10.1016/j.bbrc.2022.03.035] [Reference Citation Analysis]
13 Sen'kova AV, Savin IA, Brenner EV, Zenkova MA, Markov AV. Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study. PLoS One 2021;16:e0260450. [PMID: 34807957 DOI: 10.1371/journal.pone.0260450] [Reference Citation Analysis]
14 Castiglione F, Deb D, Srivastava AP, Liò P, Liso A. From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling. Front Immunol 2021;12:646972. [PMID: 34557181 DOI: 10.3389/fimmu.2021.646972] [Reference Citation Analysis]
15 Ali ET, Sajid Jabbar A, Al Ali HS, Shaheen Hamadi S, Jabir MS, Albukhaty S, Li J. Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients. International Journal of Inflammation 2022;2022:1-11. [DOI: 10.1155/2022/5735546] [Reference Citation Analysis]
16 Gupta RK, Nwachuku EL, Zusman BE, Jha RM, Puccio AM. Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium. PLoS One 2021;16:e0257784. [PMID: 34582497 DOI: 10.1371/journal.pone.0257784] [Reference Citation Analysis]
17 Geraili Z, Hajian-Tilaki K, Bayani M, Hosseini SR, Khafri S, Ebrahimpour S, Javanian M, Babazadeh A, Shokri M. Prognostic accuracy of inflammatory markers in predicting risk of ICU admission for COVID-19: application of time-dependent receiver operating characteristic curves. J Int Med Res 2022;50:3000605221102217. [PMID: 35701893 DOI: 10.1177/03000605221102217] [Reference Citation Analysis]
18 Parimoo A, Biswas A, Baitha U, Gupta G, Pandey S, Ranjan P, Gupta V, Barman Roy D, Prakash B, Wig N. Dynamics of Inflammatory Markers in Predicting Mortality in COVID-19. Cureus 2021;13:e19080. [PMID: 34868744 DOI: 10.7759/cureus.19080] [Reference Citation Analysis]